Table 5 Stent Thrombosis at 3 years.

From: An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial

Stent Thrombosis

Cordimax

Xience V

RR(95% CI)

P value

(n = 2460)

(n = 1237)

Definite

10 (0.4%)

7 (0.6%)

0.50 (0.07–3.57)

0.61

Probable

0 (0%)

0 (0%)

—

—

Definite or Probable

10 (0.4%)

7 (0.6%)

0.50 (0.07–3.57)

0.61

  1. Values are n (%). *Relative risk (RR) and p values are from the chi-square test.
Back to article page